Specifically, we found that the increase in miR-182 leads to the suppression of SOX2. Although miR-182 has been shown to target and regulate SOX2 previously in cochlea development and glioblastoma [54, 55], our study demonstrated the functional relevance of this regulatory connection in the context of SI development. The gene discussed is SOX2; the disease is glioblastoma.